Disease Prevention, Therapeutics and Diagnostics

Focus of our research

This is a cross-cutting theme aimed at novel scientific and clinical approaches to support the development of modern-day therapeutics discovery and development, and disease prevention.

We have expertise in areas including; target selection and validation, lead molecule identification and optimisation, computational drug design and disease modelling. This incorporates the work being done by Professor Mark Wheatley, who has an international reputation for his research into the structure and function of G-protein-coupled receptors (GPCRs).

Our interests include SARS-CoV-2, the immune response, metabolic disease, cardiovascular disease, cardioprotective strategies and drug safety.

We develop, test and implement clinical diagnostic, therapeutic and complex behaviour change interventions to improve health and healthcare in the community and NHS settings.

If you wish to find out more about this theme, please get in contact with Professor Chris Reynolds.